| Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma R Bajpai, A Sharma, A Achreja, CL Edgar, C Wei, AA Siddiqa, VA Gupta, ... Nature communications 11 (1), 1228, 2020 | 83 | 2020 |
| PCSK9 inhibition during the inflammatory stage of SARS-CoV-2 infection EP Navarese, P Podhajski, PA Gurbel, K Grzelakowska, E Ruscio, ... Journal of the American College of Cardiology 81 (3), 224-234, 2023 | 51 | 2023 |
| Targeting adhesion signaling in KRAS, LKB1 mutant lung adenocarcinoma M Gilbert-Ross, J Konen, J Koo, J Shupe, BS Robinson, WG Wiles IV, ... JCI insight 2 (5), 2017 | 47 | 2017 |
| CDK5 inhibition resolves PKA/cAMP-independent activation of CREB1 signaling in glioma stem cells S Mukherjee, C Tucker-Burden, E Kaissi, A Newsam, H Duggireddy, ... Cell reports 23 (6), 1651-1664, 2018 | 44 | 2018 |
| Genetic heterogeneity within collective invasion packs drives leader and follower cell phenotypes EL Zoeller, B Pedro, J Konen, B Dwivedi, M Rupji, N Sundararaman, ... Journal of cell science 132 (19), jcs231514, 2019 | 41 | 2019 |
| Modulating native GABAA receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death L Kallay, H Keskin, A Ross, M Rupji, OA Moody, X Wang, G Li, T Ahmed, ... Journal of neuro-oncology 142, 411-422, 2019 | 40 | 2019 |
| Development and validation of a practical model to identify patients at risk of bleeding after TAVR EP Navarese, Z Zhang, J Kubica, F Andreotti, A Farinaccio, AL Bartorelli, ... Cardiovascular Interventions 14 (11), 1196-1206, 2021 | 38 | 2021 |
| Impact of sequencing radiation therapy and immune checkpoint inhibitors in the treatment of melanoma brain metastases DAP Krummel, TH Nasti, B Izar, RH Press, M Xu, L Lowder, L Kallay, ... International Journal of Radiation Oncology* Biology* Physics 108 (1), 157-163, 2020 | 35 | 2020 |
| Optimal timing and treatment strategy for pancreatic cancer AC Gamboa, M Rupji, JM Switchenko, RM Lee, MK Turgeon, BI Meyer, ... Journal of surgical oncology 122 (3), 457-468, 2020 | 34 | 2020 |
| MERTK inhibition induces polyploidy and promotes cell death and cellular senescence in glioblastoma multiforme A Sufit, AB Lee-Sherick, D DeRyckere, M Rupji, B Dwivedi, ... PloS one 11 (10), e0165107, 2016 | 33 | 2016 |
| Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia M Lee, JAG Hamilton, GR Talekar, AJ Ross, L Michael, M Rupji, ... Nature Communications 13 (1), 1157, 2022 | 28 | 2022 |
| Gliosarcoma: distinct molecular pathways and genomic alterations identified by DNA copy number/SNP microarray analysis L Lowder, J Hauenstein, A Woods, HR Chen, M Rupji, J Kowalski, ... Journal of Neuro-oncology 143, 381-392, 2019 | 26 | 2019 |
| NEO-GAP: a single-arm, phase II feasibility trial of neoadjuvant gemcitabine, cisplatin, and nab-paclitaxel for resectable, high-risk intrahepatic cholangiocarcinoma SK Maithel, JM Keilson, HST Cao, M Rupji, A Mahipal, BS Lin, MM Javle, ... Annals of surgical oncology 30 (11), 6558-6566, 2023 | 23 | 2023 |
| NEO-GAP: A phase II single-arm prospective feasibility study of neoadjuvant gemcitabine/cisplatin/nab-paclitaxel for resectable high-risk intrahepatic cholangiocarcinoma. SK Maithel, MM Javle, A Mahipal, BSL Lin, M Akce, JM Switchenko, ... Journal of Clinical Oncology 40 (16_suppl), 4097-4097, 2022 | 22 | 2022 |
| Comparison of rates of adherence to oral chemotherapy medications filled through an internal health-system specialty pharmacy vs external specialty pharmacies CC McCabe, MS Barbee, ML Watson, A Billmeyer, CE Lee, M Rupji, ... American Journal of Health-System Pharmacy 77 (14), 1118-1127, 2020 | 21 | 2020 |
| Efficacy based ginger fingerprinting reveals potential antiproliferative analytes for triple negative breast cancer L Zhao, M Rupji, I Choudhary, R Osan, S Kapoor, HJ Zhang, C Yang, ... Scientific Reports 10 (1), 19182, 2020 | 16 | 2020 |
| NOJAH: not just another heatmap for genome-wide cluster analysis M Rupji, B Dwivedi, J Kowalski PLoS One 14 (3), e0204542, 2019 | 16 | 2019 |
| ETV2/ER71 regulates the generation of FLK1+ cells from mouse embryonic stem cells through miR-126-MAPK signaling JY Kim, DH Lee, JK Kim, HS Choi, B Dwivedi, M Rupji, J Kowalski, ... Stem Cell Research & Therapy 10, 1-9, 2019 | 15 | 2019 |
| 14-3-3ζ binds the proteasome, limits proteolytic function and enhances sensitivity to proteasome inhibitors. LS Gu Y, Xu K, Torre C, Samur M, Barwick BG, Rupji M, Arora J, Neri P ... Leukemia 32 (3), 744-751, 2018 | 15 | 2018 |
| CASAS: Cancer Survival Analysis Suite, a web based application M Rupji, X Zhang, J Kowalski F1000Research 6, 2017 | 15 | 2017 |
